InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,194.00
(
-0.07%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.78
(
0.90%
)
Bitcoin
60,912.73
(
-3.57%
)
Post# of 252311
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: biocqr post# 219670

Tuesday, 06/19/2018 11:00:06 AM

Tuesday, June 19, 2018 11:00:06 AM

Post# of 252311
SRPT:

As important from Adam's STAT article (missed it if was mentioned on SRPT call) is they will modify the study and go for approval on the one trial (I speculated as such on twitter on more than one occasion)!

https://www.statnews.com/2018/06/19/sarepta-gene-therapy-duchenne-early-results/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up